Antipsicóticos atípicos e comportamento suicida em pacientes esquizofrênicos ou esquizoafetivos
5 pág.

Antipsicóticos atípicos e comportamento suicida em pacientes esquizofrênicos ou esquizoafetivos


DisciplinaPsiquiatria II171 materiais1.945 seguidores
Pré-visualização4 páginas
Rev Psiquiatr Clín. 2008;35(1):13-6.
Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, et 8. 
al. Clinical response and risk for reported suicidal ideation and suicide 
attempts in pediatric antidepressant treatment: a meta-analysis of ran-
domized controlled trials. JAMA. 2007;297(15):1683-96. 
Hennen J, Baldessarini RJ. Suicidal risk during treatment with clozapine: 9. 
a meta-analysis. Schizophr Res. 2005;73(2-3):139-45. 
Sernyak MJ, Desai R, Stolar M, Rosenheck R. Impact of clozapine on 10. 
completed suicide. Am J Psychiatry. 2001;158(6):931-7.
Meltzer HY, Okayli G.11. Reduction of suicidality during clozapine tre-
atment of neuroleptic-resistant schizophrenia: impact on risk-benefit 
assessment. Am J Psychiatry. 1995;152(2):183-90.
Walker AM, Lanza LL, Arellano F, Rothman KJ. Mortality in current and 12. 
former users of clozapine. Epidemiology. 1997;8(6):671-7.
13. Reid WH, Mason M, Hogan T. Suicide prevention effects associated 
with clozapine therapy in schizophrenia and schizoaffective disorder. 
Psychiatr Serv. 1998;49(8):1029-33.
Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, et al. 14. 
International Suicide Prevention Trial Study Group. Clozapine treatment 
for suicidality in schizophrenia: International Suicide Prevention Trial 
(InterSePT). Arch Gen Psychiatry. 2003;60(1):82-91. Erratum in: Arch 
Gen Psychiatry. 2003;60(7):735.
Glick ID, Zaninelli R, Hsu C, Young FK, Weiss L, Gunay I, et al. Patterns 15. 
of concomitant psychotropic medication use during a 2-year study com-
paring clozapine and olanzapine for the prevention of suicidal behavior. 
J Clin Psychiatry. 2004;65(5):679-85.
Addington D, Addington J, Schissel B. A depression rating scale for 16. 
schizophrenics. Schizophr Res. 1990;3(4):247-51.
Potkin SG, Alphs L, Hsu C, Krishnan KR, Anand R, Young FK, et al. 17. 
InterSePT Study Group. Predicting suicidal risk in schizophrenic and 
schizoaffective patients in a prospective two-year trial. Biol Psychiatry. 
2003;15;54(4):444-52.
[No authors listed] Clozaril approved for reducing risk of suicide. 18. 
FDA Consum. 2003;37(2):5.
Spivak B, Shabash E, Sheitman B, Weizman A, Mester R. The effects of 19. 
clozapine versus haloperidol on measures of impulsive aggression and 
suicidality in chronic schizophrenia patients: an open, nonrandomized, 
6-month study. J Clin Psychiatry. 2003;64(7):755-60.
Duggan A, Warner J, Knapp M, Kerwin R. Modelling the impact of 20. 
clozapine on suicide in patients with treatment-resistant schizophrenia 
in the UK. Br J Psychiatry. 2003;182:505-8.
Modestin J, Dal Pian D, Agarwalla P. Clozapine diminishes suicidal 21. 
behavior: a retrospective evaluation of clinical records. J Clin Psychiatry. 
2005;66(4):534-8.
Herings RM, Erkens JA. Increased suicide attempt rate among patients 22. 
interrupting use of atypical antipsychotics. Pharmacoepidemiol Drug 
Saf. 2003;12(5):423-4.
Barak Y, Mirecki I, Knobler HY, Natan Z, Aizenberg D. Suicidality and 23. 
second generation antipsychotics in schizophrenia patients: a case-con-
trolled retrospective study during a 5-year period. Psychopharmacology 
(Berl). 2004;175(2):215-9.
Haukka J, Tiihonen J, Härkänen T, Lönnqvist J. Association between 24. 
medication and risk of suicide, attempted suicide and death in nationwide 
cohort of suicidal patients with schizophrenia. Pharmacoepidemiol Drug 
Saf. 2008;17(7):686-96.
Aguilar EJ, Siris SG. Do antipsychotic drugs influence suicidal behavior 25. 
in schizophrenia? Psychopharmacol Bull. 2007;40(3):128-42.
Ayer DW, Jayathilake K, Meltzer HY. Th26. e InterSePT suicide scale for predic-
tion of imminent suicidal behaviors. Psychiatry Res. 2008;161(1):87-96.
Meltzer HY. Suicide in schizophrenia: risk factors and clozapine treat-27. 
ment. J Clin Psychiatry. 1998;59(Suppl 3):15-20.
Mann JJ, Arango VA, Avenevoli S, Brent DA, Champagne FA, Clayton P, 28. 
et al. Candidate endophenotypes for genetic studies of suicidal behavior. 
Biol Psychiatry. 2009;65(7):556-63.
232 Rocha FF, et al. / Rev Psiq Clín. 2010;37(5):228-32
Ferreira AD, Neves FS, da Rocha FF, Silva GS, Romano-Silva MA, 29. 
Miranda DM, et al. The role of 5-HTTLPR polymorphism in antide-
pressant-associated mania in bipolar disorder. J Affect Disord. 2009; 
112(1-3):267-72.
Munro J, O\u2019Sullivan D, Andrews C, Arana A, Mortimer A, Kerwin 30. 
R. Active monitoring of 12,760 clozapine recipients in the UK and 
Ireland. Beyond pharmacovigilance. Br J Psychiatry. 1999;175: 
576-80.
Rocha FF, Malloy-Diniz L, de Sousa KC, Prais HA, Correa H, Teixeira 31. 
AL. Borderline personality features possibly related to cingulate and 
orbitofrontal cortices dysfunction due to schizencephaly. Clin Neurol 
Neurosurg. 2008;110(4):396-9.